{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Direct Oral Anticoagulants in Patients Cancer

Purpose of Activity

To provide information on the use of direct oral anticoagulants in cancer patients for venous thromboembolism (VTE) prophylaxis or treatment.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

Summarize findings from recent trials on the use of oral Factor Xa inhibitors in the prevention or treatment of cancer-associated thromboembolism.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: OT0419
Published: April 2019
Expires: 3/5/2021
Sources: Oncology Times
Passing Score: 7/10 (70%)
Authors: Lisa Lohr, PharmD, BCPS, BCOP